This has further driven the essentiality of hematology diagnostics with greater efficacy, thereby complementing new product developments and technological advancements in the hematology diagnostics market worldwide. There has been a marked rise in the prevalence of blood disorders, and the pervasiveness of these ailments will continue to surge in the foreseeable future, according to the report. Other leading players profiled in the report on the hematology diagnostics market include HORIBA, Ltd., HemoCue AB, Mindray Medical International Limited, Danaher (Beckman Coulter, Inc.), Bio-Rad Laboratories, Inc., and Siemens Healthineers.Įmphasis on Effective Hematology Diagnostics to Surge in Line with Prevalence of Blood Cancer Key players in the hematology diagnostics market are focusing on strategic partnerships with vendors having innovative technologies, to gain a greater share with more diverse portfolios. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Abbott Laboratories, and Sysmex Corporation, will continue to uphold their lead in the hematology diagnostics market in the upcoming years. Robust portfolio, and stronger distribution footprint of these leading players, including F. The study opines that the hematology diagnostics market will continue to remain a consolidated landscape, with few established players collectively accounting for a larger share of the market. Growing popularity of modern day analyzers that offer five to seven parts white cell differential analysis, along with additional information on cell population data (CPD), large unstained cell population, and granularity index, will continue to drive growth of the hematology diagnostics market. Integrated solutions have been gaining ground in the Hematology Diagnostics Market, as growing work load has prompted pathologists to adopt methods with precision and accuracy for improved results.Īccording to a recent study of Future Market Insights (FMI), the hematology diagnostics market recorded a valuation of approximately US$ 3,500 Mn in 2017.
This medwatch report is related to mdrs: 2122870-2011-03800.Ġ3801, 03802, 03803, 03806, 03807, 03809, 03810, 03812, 03814, 03854.The hematology diagnostics market has witnessed the advent of a wide range of hematology testing solutions that combine the attributes of strainer, slider maker, and cell counter.
This reportable event was identified during a retrospective review of product complaints conducted from januthrough octofor add'l reportable events. Quality control performed on (b)(4) 2009 was within range but was out of range (>7-8 standard deviation) on the same day. Retest pt samples are aliquoted and re-centrifuged prior to analysis. The customer has established protocol of re-evaluating all troponin results that are greater than 0. System test results conformed to the mfr's published specifications. The fse completed high sensitivity (hs) system check and troponin precision test. The fse replaced the peri-tubing and the aspirate and dispense probes. The field service engineer (fse) serviced the unit on (b)(4) 2009 and discovered some peri-tubing was flattened and tubing to be very yellow.
0 kommentar(er)
